The earnings call presented a mixed picture with strong performance in dietary supplements and cost management, alongside challenges in procedure revenue and clinic attrition. The strategic reorganization is expected to drive growth, but the impacts are yet to be realized. The flat overall revenue and adjusted guidance indicate ongoing challenges.

Company Guidance -

Q3 2025

During Biote's second quarter 2025 earnings call, the company provided updated guidance and strategic insights. Biote adjusted its fiscal 2025 revenue guidance to exceed $190 million, with adjusted EBITDA projected to surpass $50 million. These adjustments reflect a projected high single-digit decline in procedure revenue and mid-teens growth in dietary supplements. The company reported a 19.1% increase in adjusted EBITDA, reaching $15.2 million, and a 280 basis point improvement in gross profit margin to 71.6%. Despite a flat revenue at $48.9 million, Biote experienced an 8.4% decline in procedure revenue, partially offset by a 30.4% increase in dietary supplement sales. The company attributed the procedure revenue shortfall to slower new clinic additions, higher attrition of existing clinics, and lower procedure volumes. Strategic initiatives, including organizational restructuring, aim to enhance growth, improve commercial productivity, and strengthen relationships with practitioners, while foundational priorities focus on internal efficiency and process improvements.

Dietary Supplement Sales Growth

Dietary supplement revenue increased by 30.4% to $10.7 million, primarily driven by growth in the e-commerce channel.

Improved Gross Profit Margin

Gross profit margin increased by 280 basis points to 71.6%, primarily due to cost savings from vertical integration of the 503(B) manufacturing facility.

Decreased SG&A Expenses

Selling, general, and administrative expenses decreased by 12.2% to $24.2 million, partly due to the timing shift of the annual marketing event and headcount adjustments.

Increased Adjusted EBITDA

Adjusted EBITDA increased by 19.1% to $15.2 million, with an adjusted EBITDA margin of 31.1%.

biote (BTMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

BTMD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	0.08 / -	0.33	―	―	―
Aug 06, 2025	2025 (Q2)	0.08 / 0.10	-0.19	152.63% (+0.29)	―
May 07, 2025	2025 (Q1)	0.08 / 0.37	-0.06	716.67% (+0.43)	―
Mar 12, 2025	2024 (Q4)	0.11 / 0.10	0.18	-44.44% (-0.08)	―
Nov 12, 2024	2024 (Q3)	0.12 / 0.33	0.24	37.50% (+0.09)	―
Aug 08, 2024	2024 (Q2)	0.09 / -0.19	-0.25	24.00% (+0.06)	―
May 07, 2024	2024 (Q1)	0.05 / -0.06	-0.39	84.62% (+0.33)	―
Mar 12, 2024	2023 (Q4)	0.08 / 0.18	0.18	0.00% (0.00)	―
Nov 07, 2023	2023 (Q3)	0.07 / 0.24	-1.74	113.79% (+1.98)	―
Aug 10, 2023	2023 (Q2)	0.10 / -0.25	1.355	-118.45% (-1.60)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

BTMD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$3.86	$2.92	-24.35%
May 07, 2025	$3.34	$3.74	+11.98%
Mar 12, 2025	$4.10	$3.07	-25.12%
Nov 12, 2024	$5.52	$6.72	+21.74%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does biote (BTMD) report earnings?

biote (BTMD) is schdueled to report earning on Nov 11, 2025, After Close (Not Confirmed).

What is biote (BTMD) earnings time?

biote (BTMD) earnings time is at Nov 11, 2025, After Close (Not Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is BTMD EPS forecast?

BTMD EPS forecast for the fiscal quarter 2025 (Q3) is 0.08.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing